 Good evening, Our research team is preparing to share its next stock idea tomorrow, shortly before 12:00 p.m. Eastern. Subscribers who sign up for The Early Bird Stock of the Day by text will receive the alert first. Email newsletter subscribers will receive it the following morning. Join the list today to be among the first to see our next stock idea. Our previous pick generated significant interest among subscribers. The Early Bird Stock of the Day is a free service from The Early Bird and MarketBeat. Click below to sign up for future alerts: Get The Early Bird Stock of the Day William Bushee
Editor, Early Bird Team
Further Reading from MarketBeat Media
LightPath’s Defense Pivot Could Send Shares HigherAuthored by Thomas Hughes. Originally Published: 9/15/2026. 
Key Points
- LightPath Technologies is shifting toward defense and counter-drone optics, divesting China-based assets while serving clients like Anduril and Lockheed Martin.
- Fiscal Q4 revenue rose 73% year-over-year to over $21 million, with backlog swelling nearly 200% to almost $111 million.
- Analysts hold a Moderate Buy consensus with 83% buy-side bias, though wider net losses and rising capital expenditures temper near-term optimism.
- Special Report: Analyst nicknamed “The Prophet” issues new warning for America
LightPath Technologies (NASDAQ: LPTH) is turning a corner, and investors should take note. The once globally focused business is taking a more domestic approach by divesting its China-based assets to comply with the National Defense Authorization Act. That alone is a potential catalyst, particularly given the company’s shift toward defense and counter-drone technologies. LightPath’s infrared and germanium-free optics are critical to high-performance thermal imaging, including ruggedized defense and aerospace applications, and are in increasingly high demand.
Business is supported by clients such as Anduril and Lockheed Martin (NYSE: LMT), which use the technology in their most advanced systems. Anduril, specifically, uses it in its AI-powered command-and-control platform, while Lockheed Martin is working to integrate it into numerous applications. LightPath’s backlog swelled by nearly 200% in fiscal Q4, and the likelihood is that growth will continue to accelerate. LightPath is emerging as a critical cog in the defense supply chain, not only because of its capabilities and the strategic advantages they provide, but also because of its role in addressing critical-mineral concerns. Germanium is a critical mineral controlled by China, and LightPath provides an alternative. The company uses proprietary chalcogenide glass, marketed as BlackDiamond, which performs well while enabling size, weight, and power (SWaP) optimization—an important consideration for range and payloads. Autonomous vehicles using BlackDiamond are lighter, enabling longer ranges and larger payloads. LightPath Has an Illuminating Quarter, Revealing a Robust Growth TrajectoryLightPath posted a solid quarter, with fiscal Q4 revenue up 73% year over year (YOY) to just over $21 million, beating analyst expectations. This marked the fourth consecutive quarter of year-over-year acceleration, with strong results expected in the coming year. The backlog, worth nearly $111 million at quarter-end, is mostly current, with $85.6 million deliverable within the next 12 months. That alone represents roughly 20% growth and will be compounded by new orders. Margin is another bright spot, with operating metrics improving, although net losses remain part of the story. Highlights included a 900-basis-point increase in gross margin and $4.2 million in adjusted EBITDA. Looking ahead, losses are expected to continue as the company ramps capital expenditures (CapEx) and increases investment in capacity expansion. The good news is that margin expansion came from product mix and throughput rather than price increases, revealing improving profitability as the company scales. The biggest risks now lie in execution and costs, as the company is leaning heavily into expansion and recently diluted shareholders. The offset is that the dilution injected enough capital to extend the company’s runway and provide better visibility. As it stands, LightPath is fully funded through next year and may not require additional capital. The balance sheet reflects the share sales, with cash up nearly $90 million year over year and virtually no debt. Analysts Respond With Cautious OptimismAnalysts responded to the release with optimism, citing the backlog and expansion plans, but they also expressed caution. Wider-than-expected net losses and increased CapEx led to some earnings-forecast reductions. The group expects LightPath to become profitable in fiscal 2028, so an inflection point is ahead. Until then, the consensus of the six analysts MarketBeat tracks is a Moderate Buy, with an 83% buy-side bias. They see the stock advancing 55% to the consensus midpoint and as high as $15.50 at the upper end of their estimates. The likely outcome is that analysts remain cautious in the near term but potentially warm to the stock over the coming quarters as the company executes on its capacity expansion and backlog. Institutional activity is telling. Institutions own more than 55% of the stock, a significant stake for a company with such a small market capitalization, and are aggressively accumulating shares. While activity has been bullish for several consecutive quarters, third-quarter activity is noteworthy, spiking to record levels alongside the stock-price correction. The takeaway is that institutional traders recognized the opportunity and are capitalizing on it. 
The price chart shows an oversold stock that appears ready to rebound, potentially very strongly. Not only does the stochastic indicator show a bullish crossover low in its signal range, but MACD divergence suggests the bottom may be in. In this scenario, LPTH could begin rebounding soon, although it may not experience a robust recovery until later in the year or early 2027. Short sellers remain active, creating a headwind for the stock that may not ease without a strongly bullish catalyst. Customer concentration and contract delays are among the risks. LightPath’s role in the defense supply chain exposes it to program and supply-chain delays beyond its control. Recent delays include the Army’s Next Generation Short Range Interceptor schedule and redesigns on other projects. . |
